DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 188 filers reported holding DENALI THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $408,206 | -81.0% | 19,787 | -78.8% | 0.02% | -82.0% |
| Q1 2023 | $2,151,268 | -31.4% | 93,371 | -8.6% | 0.09% | -27.6% |
| Q3 2022 | $3,135,000 | +646.4% | 102,152 | +614.5% | 0.12% | +583.3% |
| Q2 2022 | $420,000 | -7.7% | 14,297 | +40.1% | 0.02% | -37.9% |
| Q4 2021 | $455,000 | -44.3% | 10,203 | -28.7% | 0.03% | -61.8% |
| Q1 2021 | $817,000 | +204.9% | 14,300 | +346.9% | 0.08% | +65.2% |
| Q4 2020 | $268,000 | – | 3,200 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Crestline Management, LP | 7,460,732 | $240,012,000 | 28.78% |
| Casdin Capital, LLC | 1,500,000 | $48,255,000 | 2.16% |
| Flagship Pioneering Inc. | 2,619,968 | $84,284,000 | 1.98% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 38,000 | $8,192,000 | 1.85% |
| Yiheng Capital Management, L.P. | 1,014,684 | $32,642,000 | 1.49% |
| SECTORAL ASSET MANAGEMENT INC | 207,100 | $6,662,000 | 1.18% |
| Artal Group S.A. | 600,000 | $19,302,000 | 0.81% |
| GILDER GAGNON HOWE & CO LLC | 2,619,217 | $84,260,000 | 0.78% |
| Temasek Holdings (Private) Ltd | 5,369,487 | $172,736,397 | 0.73% |
| BRANDYWINE MANAGERS, LLC | 9,601 | $309,000 | 0.53% |